Lin et al., 2021 - Google Patents
A tri-functional amino acid enables mapping of binding sites for posttranslational-modification-mediated protein-protein interactionsLin et al., 2021
View HTML- Document ID
- 2623061556011014372
- Author
- Lin J
- Bao X
- Li X
- Publication year
- Publication venue
- Molecular Cell
External Links
Snippet
Posttranslational modification (PTM), through the recruitment of effector proteins (ie," readers") that signal downstream events, plays key roles in regulating a variety of cellular processes. To understand how a PTM is recognized, it is necessary to find its readers and …
- 230000004481 post-translational protein modification 0 title abstract description 67
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | A tri-functional amino acid enables mapping of binding sites for posttranslational-modification-mediated protein-protein interactions | |
| Farrelly et al. | Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3 | |
| Skrajna et al. | Comprehensive nucleosome interactome screen establishes fundamental principles of nucleosome binding | |
| Bao et al. | Glutarylation of histone H4 lysine 91 regulates chromatin dynamics | |
| Padrón et al. | Proximity RNA labeling by APEX-seq reveals the organization of translation initiation complexes and repressive RNA granules | |
| Nguyen et al. | Expanding the genetic code to study protein–protein interactions | |
| Hohmann et al. | Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition | |
| Yang et al. | Spontaneous and specific chemical cross-linking in live cells to capture and identify protein interactions | |
| Chavez et al. | Protein interactions, post-translational modifications and topologies in human cells | |
| Matic et al. | Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif | |
| Ghosh et al. | Unique physical properties and interactions of the domains of methylated DNA binding protein 2 | |
| Li et al. | Quantitative chemical proteomics approach to identify post-translational modification-mediated protein–protein interactions | |
| Roux | Marked by association: techniques for proximity-dependent labeling of proteins in eukaryotic cells | |
| Sathe et al. | Proteomic approaches advancing targeted protein degradation | |
| Melvin et al. | Measuring activity in the ubiquitin–proteasome system: From large scale discoveries to single cells analysis | |
| Gama-Brambila et al. | A PROTAC targets splicing factor 3B1 | |
| Wu et al. | IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors | |
| Roeselová et al. | Mechanism of chaperone coordination during cotranslational protein folding in bacteria | |
| Hoffmann et al. | A bifunctional noncanonical amino acid: synthesis, expression, and residue-specific proteome-wide incorporation | |
| Luo et al. | The cAMP Capture Compound Mass Spectrometry as a Novel Tool for Targeting cAMP-binding Proteins*: FROM PROTEIN KINASE A TO POTASSIUM/SODIUM HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS | |
| Li et al. | Spatiotemporal protein interactome profiling through condensation-enhanced photocrosslinking | |
| Barth et al. | Identification of novel Drosophila centromere‐associated proteins | |
| Valletta et al. | Exploring the interaction between the SWI/SNF chromatin remodeling complex and the zinc finger factor CTCF | |
| Bian et al. | Protocol for establishing a protein-protein interaction network using tandem affinity purification followed by mass spectrometry in mammalian cells | |
| Wang et al. | Development of nucleus-targeted histone-tail-based photoaffinity probes to profile the epigenetic interactome in native cells |